KEYSTROKE, NCT03546582: SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma |
|
|
| Recruiting | 2 | 102 | Canada, US | Pembrolizumab, Keytruda, Stereotactic Body Radiation Therapy (SBRT), SBRT | RTOG Foundation, Inc., Merck Sharp & Dohme LLC | Head and Neck Squamous Cell Carcinoma (HNSCC) | 07/27 | 07/29 | | |
NCT04797390: A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema |
|
|
| Active, not recruiting | N/A | 250 | US | Advanced Pneumatic Compression Device (APCD), Flexitouch, Flexitouch Plus, Usual Care, Complete Decongestive Therapy (CDT), Manual Lymphatic Drainage (MLD) | Tactile Medical, Vanderbilt University Medical Center | Lymphedema, Lymphedema of Face, Lymphedema, Secondary, Lymphedema Due to Radiation, Lymphedema; Surgical | 01/25 | 01/25 | | |
| Terminated | 1 | 64 | US | MT-6402 | Molecular Templates, Inc. | Advanced Solid Tumor, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck | 10/24 | 10/24 | | |